{"title":"Erratum regarding previously published articles","authors":"","doi":"10.1016/j.jfop.2025.100165","DOIUrl":"10.1016/j.jfop.2025.100165","url":null,"abstract":"","PeriodicalId":100740,"journal":{"name":"JFO Open Ophthalmology","volume":"10 ","pages":"Article 100165"},"PeriodicalIF":0.0,"publicationDate":"2025-04-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143820323","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Corneal innervation and neurotisation: a review of current concepts","authors":"Christian P. Pappas","doi":"10.1016/j.jfop.2025.100163","DOIUrl":"10.1016/j.jfop.2025.100163","url":null,"abstract":"<div><div>The cornea is the most richly innervated tissue within the body, the complexity of which reflects the critical role of visual preservation to survival. Sensation is provided almost solely by innervation of the ophthalmic nerve, where any insult along the afferent sensory pathway may result in the development of neurotrophic keratopathy, a vision-threatening condition. We review the current model of corneal sensory and autonomic innervation and explore the typical aetiologic and pathogenic features of neurotrophic keratopathy. Special attention is given to corneal neurotisation, an effective microsurgical treatment for moderate to severe neurotrophic keratopathy refractory to non-surgical management techniques, and its role in the reinnervation of the asensate cornea by direct or indirect transplantation of healthy nerve tissue.</div></div>","PeriodicalId":100740,"journal":{"name":"JFO Open Ophthalmology","volume":"10 ","pages":"Article 100163"},"PeriodicalIF":0.0,"publicationDate":"2025-03-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143768108","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Monali S. Malvankar-Mehta , Hyunsoo (Jason) Jang , Brian Yu , Cindy Hutnik
{"title":"Effects of Sahaj Samadhi Meditation on health-related quality of life of glaucoma patients: A feasibility study","authors":"Monali S. Malvankar-Mehta , Hyunsoo (Jason) Jang , Brian Yu , Cindy Hutnik","doi":"10.1016/j.jfop.2025.100164","DOIUrl":"10.1016/j.jfop.2025.100164","url":null,"abstract":"<div><h3>Background</h3><div>Glaucoma is a leading cause of irreversible blindness, with a growing body of literature linking it to mental disorders. This study aimed to investigate the effects of Sahaj Samadhi Meditation (SSM) on depression, anxiety, sleep quality, and community integration in patients with glaucoma.</div></div><div><h3>Methods</h3><div>A prospective feasibility study was conducted with 28 participants aged 18 and older, including those with mild to severe glaucoma and glaucoma suspects. Participants were divided into two groups: one receiving treatment as usual (TAU) and the other receiving TAU plus Sahaj Samadhi Meditation (SSM). The SSM group participated in a structured 4-day group session and were instructed to meditate regularly on their own. Assessments were conducted on vision-related quality of life (VRQOL), depressive symptoms, anxiety, sleep quality, and community integration at baseline and at the 24-week follow-up. Feasibility outcomes were measured, and statistical analysis was performed using STATA 18.0.</div></div><div><h3>Results</h3><div>The SSM group showed a significant reduction in depression and improvement in sleep quality compared to the control group. Additionally, the SSM group experienced a reduction in anxiety symptoms. However, there were no significant differences in VRQOL, and community integration between the two groups. No adverse effects were reported.</div></div><div><h3>Conclusions</h3><div>SSM may help reduce depressive symptoms and improve sleep quality in glaucoma patients. It may also alleviate anxiety symptoms. Further studies with larger sample sizes and longer follow-up periods are needed to confirm these findings.</div></div>","PeriodicalId":100740,"journal":{"name":"JFO Open Ophthalmology","volume":"10 ","pages":"Article 100164"},"PeriodicalIF":0.0,"publicationDate":"2025-03-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143696667","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Optic neuritis induced by Pembrolizumab treatment for recurrent vulvar cancer","authors":"Ariel Cohen , Yonah Levy , Kristy Ward","doi":"10.1016/j.jfop.2025.100162","DOIUrl":"10.1016/j.jfop.2025.100162","url":null,"abstract":"<div><h3>Purpose</h3><div>To describe a novel case of optic neuritis induced after pembrolizumab treatment for recurrent vulvar cancer.</div></div><div><h3>Background</h3><div>Immunotherapy is becoming increasingly important as a therapy for cases of vulvar cancer that are resistant to standard treatment.</div></div><div><h3>Case presentation</h3><div>A 53-year-old female with a history of recurrent vulvar cancer presented with sudden-onset progressive vision loss in both eyes for four weeks. Initially patient was thought to have brain metastases based on imaging, but after a thorough workup, the diagnosis of optic neuritis was made. Pembrolizumab therapy was immediately ceased, and high-dose corticosteroids were used to treat the patient effectively and reverse her symptoms.</div></div><div><h3>Conclusions</h3><div>Several cases of CNS toxicity and optic neuritis have been reported with the use of pembrolizumab immunotherapy but, to our knowledge, this is the first reported case to have occurred in the setting of recurrent vulvar cancer. In these cases it is important to have prompt discontinuation of the offending agent and treatment with high-dose corticosteroid course.</div></div>","PeriodicalId":100740,"journal":{"name":"JFO Open Ophthalmology","volume":"10 ","pages":"Article 100162"},"PeriodicalIF":0.0,"publicationDate":"2025-03-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143726059","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Cataract co-existing with glaucoma: A case of Klippel-Trénaunay Syndrome","authors":"Shubham Manchanda, Savleen Kaur, Sushmita Kaushik, Jaspreet Sukhija","doi":"10.1016/j.jfop.2025.100158","DOIUrl":"10.1016/j.jfop.2025.100158","url":null,"abstract":"","PeriodicalId":100740,"journal":{"name":"JFO Open Ophthalmology","volume":"9 ","pages":"Article 100158"},"PeriodicalIF":0.0,"publicationDate":"2025-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143337609","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Validation of the Brazilian Portuguese version of the cat-PROM5 questionnaire","authors":"Adriano Cypriano Faneli , Ricardo Danilo Chagas Oliveira , Eduardo F. Marback , Murilo Barreto Souza , Patricia F. Marback , Larrie Laporte , Cristina Muccioli","doi":"10.1016/j.jfop.2025.100155","DOIUrl":"10.1016/j.jfop.2025.100155","url":null,"abstract":"<div><h3>Objectives</h3><div>Cataract surgery is the most common and effective treatment for cataract-related visual impairment, yet traditional measures of visual acuity do not fully capture patient-reported improvement in visual function. The Cat-PROM5, a five-item tool, was developed to assess cataract-related visual disability and its impact on quality of life, with validation in other languages but not in Brazilian Portuguese. This study aimed to validate the Brazilian Portuguese version of the Cat-PROM5.</div></div><div><h3>Methods</h3><div>A cross-sectional study was conducted with 144 patients undergoing cataract surgery at a tertiary hospital in Brazil. Participants completed the Cat-PROM5 preoperatively and postoperatively to assess changes in visual function. Validation included translation and cultural adaptation following International Society for Pharmacoeconomics and Outcomes Research guidelines and Rasch analysis to evaluate psychometric properties.</div></div><div><h3>Main results</h3><div>The Brazilian Portuguese Cat-PROM5 demonstrated satisfactory fit in Rasch modeling [χ² (5) = 4.757, p = 0.446] and reliability (Reliability = 0.813, ⍺ = 0.825, ω = 0.859). Test-retest reliability was high (r = 0.868), and correlations with Catquest-9SF and best-corrected visual acuity changes were significant. Threshold issues were observed in certain items, but unidimensionality and internal consistency were maintained.</div></div><div><h3>Conclusions</h3><div>The Brazilian Portuguese Cat-PROM5 is a valid, reliable, and concise tool for assessing visual disability in cataract surgery patients, enabling efficient clinical assessment with high patient response rates. Its strong psychometric properties support its use in clinical and research settings for Brazilian cataract surgery patients.</div></div>","PeriodicalId":100740,"journal":{"name":"JFO Open Ophthalmology","volume":"9 ","pages":"Article 100155"},"PeriodicalIF":0.0,"publicationDate":"2025-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143162721","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}